ACC 2025

Latest ACC 2025 News

Clopidogrel Monotherapy Significantly Reduced MACE vs Aspirin Monotherapy Post-PCI: SMART-CHOICE 3

Key Points: Standard cardiology practice recommends aspirin monotherapy indefinitely after DAPT for…

Leah Kosyakovsky

FFR-Guided PCI Associated with Higher Rates of MI Compared to CABG in MVD: Five-Year Results from FAME-3

Key Points: The FAME 3 trial tested whether percutaneous coronary intervention (PCI)…

Leah Kosyakovsky

Sudden Cardiac Arrest Survival Worse in Minorities Among Young Athletes: RACER Cohort from 2010–2023

Key Points: This study presents updated national data from the Race Associated…

Leah Kosyakovsky

Altshock2: No Benefit to IABP in HF-Cardiogenic Shock

Key Points: Prior trials have demonstrated limited benefit to intra-aortic balloon pump…

Leah Kosyakovsky

No Benefit to Fluid Restriction in Chronic HF: FRESH UP

Key Points: While fluid restriction is a standard recommendation for patients with…

Leah Kosyakovsky

Biomarkers Show Limited Utility in Guiding Early TAVR Timing for Asymptomatic Severe AS: EARLY TAVR Trial

Key Takeaways: Elevated baseline NT-proBNP and hs-cTnT levels were associated with higher…

Leah Kosyakovsky

Autologous Bone Marrow Cell Therapy Failed to Meet Primary Endpoint in Ischemic Heart Failure: CardiAMP-HF

Key Takeaways: Intramyocardial autologous bone marrow cell therapy was safe in patients…

Leah Kosyakovsky

SHR-1918 Safe, Significantly Lowered LDL-C and Triglycerides in Poorly Controlled Hyperlipidemia

Key Takeaways: SHR-1918, an ANGPTL3 inhibitor, significantly reduced LDL cholesterol by approximately…

Leah Kosyakovsky

AI-Based ECG Model Enhances Detection of Heart Attack and Need for Coronary Revascularization

Key Takeaways: A deep learning ECG model significantly outperforms clinician interpretation in…

Leah Kosyakovsky

AI Accurately Detected Severe AS on TTE but Uptake Low Amongst Clinicians: Insights from a Randomized Crossover Study

Key Points: In a randomized crossover study, authors assessed whether artificial intelligence…

Leah Kosyakovsky

PRAGUE-25: Lifestyle Modification Plus Antiarrhythmic Drugs Inferior to Catheter Ablation In Obese Patients

Key Points: Obesity increases the risk of atrial fibrillation (AF) by 19–29%…

Leah Kosyakovsky

ZENITH Trial: Sotatercept Significantly Reduces Major Morbidity and Mortality Events in High-Risk PAH Patients

Key Points: Pulmonary arterial hypertension (PAH) is a progressive disease with poor…

Leah Kosyakovsky

SUMMIT: Tirzepatide Improved Renal Function in Patients with HFpEF, Obesity, and CKD

Key Points The SUMMIT randomized control trial demonstrated that tirzepatide significantly reduced…

Leah Kosyakovsky

EKSTROM Trial: Low-dose Colchicine Reduced Total Plaque Volume on CCTA, but Not Low Attenuation Plaque

Key Points The COLCOT trial demonstrated colchicine improved coronary plaque characteristics in…

Leah Kosyakovsky

Dapagliflozin Reduced LVMI in Patients with CKD : DECODE-CKD

Key Points The DECODE-CKD trial investigated the effects of SGLT-2 inhibitor Dapagliflozin…

Leah Kosyakovsky

Benefit from Intensive BP Control Across Frailty Statuses – A Post-Hoc Analysis of ESPRIT trial

Key Points The ESPRIT trial assessed whether the efficacy and safety of…

Leah Kosyakovsky

EARLY TAVR: Delayed TAVR Linked with Increased Risk of Death, Stroke, HF, or HFH Within 2 Years

Key Points:  In this sub analysis of the EARLY TAVR trial, the…

Leah Kosyakovsky

Early, Short-Term Use of Rivaroxaban Plus DAPT Significantly Reduces Intracoronary Thrombus

Key Points:  In the ARISE-ARMYDA 7 trial, 40 patients who presented with…

Leah Kosyakovsky

Health360x.ai Successfully Implemented Decentralized Clinical Trials in Underserved Populations

Key Points: Health360x.ai is an AI-powered digital health platform designed to scale…

Leah Kosyakovsky